$17.35
+0.73
(+4.39%)▲
Insights on Afya Ltd
Revenue is up for the last 6 quarters, 580.57M → 729.86M (in $), with an average increase of 4.2% per quarter
Netprofit is up for the last 3 quarters, 82.78M → 98.06M (in $), with an average increase of 8.1% per quarter
In the last 1 year, Tal Education Group has given 105.0% return, outperforming this stock by 63.7%
5.99%
Downside
Day's Volatility :6.53%
Upside
0.57%
38.21%
Downside
52 Weeks Volatility :52.31%
Upside
22.82%
Period | Afya Ltd | Sector (Consumer Discretionary) | Index (Russel 2000) |
---|---|---|---|
3 Months | -19.44% | 1.5% | 0.0% |
6 Months | 3.81% | 17.7% | 0.0% |
1 Year | 39.78% | 21.2% | 2.2% |
3 Years | -23.8% | -2.5% | -23.0% |
Market Capitalization | 1.5B |
Book Value | $40.04 |
Earnings Per Share (EPS) | 0.82 |
PE Ratio | 20.04 |
Wall Street Target Price | 24.32 |
Profit Margin | 13.43% |
Operating Margin TTM | 23.37% |
Return On Assets TTM | 6.59% |
Return On Equity TTM | 11.76% |
Revenue TTM | 2.9B |
Revenue Per Share TTM | 32.02 |
Quarterly Revenue Growth YOY | 25.0% |
Gross Profit TTM | 1.5B |
EBITDA | 970.7M |
Diluted Eps TTM | 0.82 |
Quarterly Earnings Growth YOY | 0.47 |
EPS Estimate Current Year | 1.49 |
EPS Estimate Next Year | 1.68 |
EPS Estimate Current Quarter | 0.31 |
EPS Estimate Next Quarter | 0.47 |
What analysts predicted
Upside of 40.17%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 86.2M | ↑ 54.59% |
Net Income | 22.3M | ↑ 90.23% |
Net Profit Margin | 25.86% | ↑ 4.85% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 186.9M | ↑ 124.78% |
Net Income | 38.3M | ↑ 78.24% |
Net Profit Margin | 20.5% | ↓ 5.36% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 231.4M | ↑ 60.02% |
Net Income | 56.3M | ↑ 89.76% |
Net Profit Margin | 24.32% | ↑ 3.82% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 308.7M | ↑ 43.14% |
Net Income | 40.1M | ↓ 23.54% |
Net Profit Margin | 12.99% | ↓ 11.33% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 440.6M | ↑ 35.46% |
Net Income | 70.7M | ↑ 67.28% |
Net Profit Margin | 16.04% | ↑ 3.05% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 592.7M | ↑ 23.48% |
Net Income | 79.6M | ↑ 3.41% |
Net Profit Margin | 13.43% | ↓ 2.61% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 107.6M | ↓ 2.94% |
Net Income | 14.0M | ↓ 25.36% |
Net Profit Margin | 13.05% | ↓ 3.92% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 110.5M | ↑ 0.59% |
Net Income | 12.6M | ↓ 11.97% |
Net Profit Margin | 11.42% | ↓ 1.63% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 139.4M | ↑ 21.57% |
Net Income | 22.0M | ↑ 68.12% |
Net Profit Margin | 15.79% | ↑ 4.37% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 148.9M | ↑ 0.37% |
Net Income | 17.3M | ↓ 26.16% |
Net Profit Margin | 11.62% | ↓ 4.17% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 723.5M | ↑ 1.53% |
Net Income | 93.3M | ↑ 12.75% |
Net Profit Margin | 12.9% | ↑ 1.28% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 729.9M | ↑ 0.88% |
Net Income | 98.1M | ↑ 5.05% |
Net Profit Margin | 13.44% | ↑ 0.54% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 237.1M | ↑ 786.29% |
Total Liabilities | 84.7M | ↑ 476.94% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 725.3M | ↑ 217.12% |
Total Liabilities | 198.9M | ↑ 143.47% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 923.4M | ↑ 64.57% |
Total Liabilities | 377.5M | ↑ 145.3% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 1.2B | ↑ 34.51% |
Total Liabilities | 618.9M | ↑ 75.95% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 1.4B | ↑ 11.67% |
Total Liabilities | 747.1M | ↑ 14.56% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 7.6B | ↑ 5.35% |
Total Liabilities | 3.9B | ↓ 0.2% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.3B | ↑ 1.97% |
Total Liabilities | 664.8M | ↑ 1.3% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.4B | ↑ 6.49% |
Total Liabilities | 747.1M | ↑ 10.1% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.5B | ↑ 8.32% |
Total Liabilities | 870.0M | ↑ 12.18% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↑ 0.65% |
Total Liabilities | 919.8M | ↓ 0.61% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 7.8B | ↓ 0.23% |
Total Liabilities | 4.3B | ↓ 2.75% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 7.6B | ↓ 3.15% |
Total Liabilities | 3.9B | ↓ 7.95% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 20.7M | ↑ 101.21% |
Investing Cash Flow | -67.7M | ↑ 1088.89% |
Financing Cash Flow | 56.5M | ↓ 5405.24% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 74.5M | ↑ 272.54% |
Investing Cash Flow | -88.2M | ↑ 34.97% |
Financing Cash Flow | 229.5M | ↑ 321.05% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 71.6M | ↑ 24.16% |
Investing Cash Flow | -200.9M | ↑ 194.44% |
Financing Cash Flow | 145.7M | ↓ 17.91% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 113.3M | ↑ 69.81% |
Investing Cash Flow | -228.7M | ↑ 22.18% |
Financing Cash Flow | 65.5M | ↓ 51.79% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 159.6M | ↑ 33.77% |
Investing Cash Flow | -111.9M | ↓ 53.58% |
Financing Cash Flow | 17.6M | ↓ 74.51% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 53.4M | ↑ 93.0% |
Investing Cash Flow | -25.8M | ↓ 24.69% |
Financing Cash Flow | -9.1M | ↓ 64.14% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 24.2M | ↓ 55.54% |
Investing Cash Flow | -31.1M | ↑ 17.94% |
Financing Cash Flow | 78.4M | ↓ 943.63% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 65.1M | ↑ 158.99% |
Investing Cash Flow | -17.1M | ↓ 47.15% |
Financing Cash Flow | -10.0M | ↓ 112.26% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 43.0M | ↓ 37.89% |
Investing Cash Flow | -18.2M | ↑ 0.0% |
Financing Cash Flow | -20.9M | ↑ 97.04% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 358.7M | ↑ 74.18% |
Investing Cash Flow | -172.1M | ↑ 97.98% |
Financing Cash Flow | -105.9M | ↑ 5.74% |
Sell
Neutral
Buy
Afya Ltd is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Afya Ltd | -14.37% | 3.81% | 39.78% | -23.8% | -31.01% |
New Oriental Education & Tech Group Inc | -13.08% | 19.34% | 70.0% | -52.48% | -18.47% |
Grand Canyon Education Inc | -3.73% | 11.95% | 11.35% | 14.88% | 7.12% |
Stride Inc | -1.3% | 20.39% | 67.32% | 103.18% | 106.16% |
Graham Holdings | -3.71% | 25.2% | 25.49% | 11.46% | -2.57% |
Tal Education Group | 8.11% | 19.84% | 109.93% | -80.46% | -66.1% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Afya Ltd | 20.04 | 20.04 | NA | 1.49 | 0.12 | 0.07 | NA | 40.04 |
New Oriental Education & Tech Group Inc | 49.77 | 49.77 | 0.86 | 2.93 | 0.09 | 0.03 | NA | 23.14 |
Grand Canyon Education Inc | 18.93 | 18.93 | 1.14 | 7.65 | 0.3 | 0.18 | NA | 24.34 |
Stride Inc | 14.66 | 14.66 | 0.63 | 4.24 | 0.18 | 0.08 | NA | 24.39 |
Graham Holdings | 16.39 | 16.39 | 0.0 | 52.15 | 0.05 | 0.03 | 0.01 | 887.68 |
Tal Education Group | 2092.93 | NA | 1.84 | 0.07 | -0.02 | -0.01 | NA | 6.03 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Afya Ltd | Buy | $1.5B | -31.01% | 20.04 | 13.43% |
New Oriental Education & Tech Group Inc | Buy | $14.8B | -18.47% | 49.77 | 8.54% |
Grand Canyon Education Inc | Buy | $3.9B | 7.12% | 18.93 | 21.33% |
Stride Inc | Buy | $2.5B | 106.16% | 14.66 | 8.8% |
Graham Holdings | Sell | $3.2B | -2.57% | 16.39 | 4.65% |
Tal Education Group | Buy | $7.8B | -66.1% | 2092.93 | -5.3% |
BAMCO Inc
FMR Inc
SoftBank Group Corp
Perpetual Ltd
Credit Suisse First Boston (CSFB)
Massachusetts Financial Services Company
afya limited, through its subsidiaries, operates as a medical education group in brazil. the company provides educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. it offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil and mechanical engineering, industrial engineering, dentistry, pedagogy, nutrition, physiotherapy, psychology, architecture, veterinary medicine, and others. in addition, the company provides distance learning residency preparatory courses through its online platform; and develops and sells pr
Organization | Afya Ltd |
Employees | 0 |
CEO | Mr. Virgilio Deloy Capobianco Gibbon |
Industry | Consumer Services |